Pairwise Plants has closed a $25m Series A funding round co-led by Deerfield Management and Monsanto Growth Ventures (MGV), the venture capital arm of Monsanto to accelerate crop innovation. Pairwise is an agricultural company focused on ...
It's been announced a group of Chinese scientists are going to be joining an expert panel later this year to lay out guidelines for a controversial new procedure connected to human genome research. The Chinese Academy of Sciences will ...
Tags: Human Gene Editing
Thanks to a powerful new gene-editing technique, scientists have overcome a major hurdle for humans to receive life-saving organ transplants from pigs. In a paper in the U.S. journal Science this week, the researchers described using the ...
Tags: Gene Editing, Organ Transplant
The world-renowned journal Nature Thursday released its annual list of ten people who mattered in science in 2015, which includes one Chinese scientist whose work in human embryo gene editing has caused repeated debate in the academic ...
Tags: Chinese Scientist, human embryo gene editing, Nature's Ten
Porcine reproductive and respiratory syndrome (PRRS) virus has been terrorizing the pork industry for over 25 years, but the end may be in sight. Researchers and scientists from the University of Missouri, Kansas State University, and Genus ...
A simple adjustment to a powerful gene-editing tool may be able to improve its specificity.In a report receiving advance online publication in Nature Biotechnology,Massachusetts General Hospital(MGH)investigators describe how adjusting the ...
Biogen Idec (NASDAQ: BIIB) and Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today an exclusive worldwide collaboration and license agreement focused on the development of therapeutics for hemoglobinopathies, inherited conditions that ...
Editas Medicine, a transformative genome editing company, today announced it has secured a $43m Series A financing led by Flagship Ventures, Polaris Partners and Third Rock Ventures with participation from Partners Innovation Fund. ...
Tags: Editas Medicine, genome editing
US-based Transposagen Biopharmaceuticals has announced today the issuing of a patent entitled, ‘Nucleic Acids Encoding Hyperactive PiggyBac Transposases’ on 19 March 2013 and a patent entitled, ‘A Genetically Modified Rat ...
Tags: Transposagen, Medicine
Sangamo BioSciences has received a $6.4m strategic partnership grant from the California Institute for Regenerative Medicine (CIRM) for the development of ZFP Therapeutic for Beta-thalassemia. The application of its zinc finger nuclease ...
Tags: Sangamo, ZFG Therapeutic
US-based drug discovery and development service company Crown Bioscience and Horizon Discovery have entered into a two year collaboration agreement to provide combined solutions for in vivo model development. Under the partnership, ...